Detalles de la búsqueda
1.
ADPGK-AS1 long noncoding RNA switches macrophage metabolic and phenotypic state to promote lung cancer growth.
EMBO J
; 42(18): e111620, 2023 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545364
2.
Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia.
Eur Respir J
; 59(2)2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34446466
3.
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
Int J Clin Pract
; 75(11): e14852, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516703
4.
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
BMC Complement Altern Med
; 19(1): 59, 2019 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871514
5.
Kinetic characterization of lactate dehydrogenase in normal and malignant human breast tissues.
Cancer Cell Int
; 15: 19, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25705126
6.
CXCL10 deficiency limits macrophage infiltration, preserves lung matrix, and enables lung growth in bronchopulmonary dysplasia.
Inflamm Regen
; 43(1): 52, 2023 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37876024
7.
Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity.
Elife
; 112022 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36074553
8.
Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial.
Eur J Gastroenterol Hepatol
; 34(3): 345-353, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34860705
9.
Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD.
Cells
; 11(13)2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35805204
10.
Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
Trials
; 22(1): 801, 2021 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34774104
11.
Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment.
Eur Respir Rev
; 29(157)2020 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33004525
12.
Cancer and pulmonary hypertension: Learning lessons and real-life interplay.
Glob Cardiol Sci Pract
; 2020(1): e202010, 2020 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150154
13.
Epithelial cell plasticity defines heterogeneity in lung cancer.
Cell Signal
; 65: 109463, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31693875
14.
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma.
Cancer Res
; 80(20): 4414-4425, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32699134
15.
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
Nutr Metab (Lond)
; 16: 8, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30705687
16.
Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
Eur J Gastroenterol Hepatol
; 20(2): 131-4, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18188034
17.
Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial.
Nutr Metab (Lond)
; 15: 63, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30263038
18.
Role of malate dehydrogenase in facilitating lactate dehydrogenase to support the glycolysis pathway in tumors.
Biomed Rep
; 6(4): 463-467, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28413646
19.
Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
BMJ Open
; 7(7): e016914, 2017 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28698350
20.
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Trials
; 18(1): 260, 2017 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28592311